Search by Drug Name or NDC
NDC 66794-0160-02 MITIGO 200 mg/20mL Details
MITIGO 200 mg/20mL
MITIGO is a EPIDURAL; INTRATHECAL INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Piramal Critical Care, Inc.. The primary component is MORPHINE SULFATE.
MedlinePlus Drug Summary
Morphine injection is used to relieve moderate to severe pain. Morphine is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 66794-0160-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Morphine Injection
Product Information
| NDC | 66794-0160 |
|---|---|
| Product ID | 66794-160_0d7e38ea-9993-52b5-e063-6394a90a7a95 |
| Associated GPIs | 65100055302020 |
| GCN Sequence Number | 052253 |
| GCN Sequence Number Description | morphine sulfate/PF VIAL 10 MG/ML INJECTION |
| HIC3 | H3A |
| HIC3 Description | OPIOID ANALGESICS |
| GCN | 19837 |
| HICL Sequence Number | 025277 |
| HICL Sequence Number Description | MORPHINE SULFATE/PF |
| Brand/Generic | Brand |
| Proprietary Name | MITIGO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Morphine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | EPIDURAL; INTRATHECAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/20mL |
| Substance Name | MORPHINE SULFATE |
| Labeler Name | Piramal Critical Care, Inc. |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | ANDA |
| Application Number | ANDA204393 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66794-0160-02 (66794016002)
| NDC Package Code | 66794-160-02 |
|---|---|
| Billing NDC | 66794016002 |
| Package | 1 mL in 1 VIAL, SINGLE-USE (66794-160-02) |
| Marketing Start Date | 2019-02-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |